MassDevice.com +5 | The top 5 medtech stories for November 28, 2016

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Navidea deals NA Lymphoseek rights to Cardinal Health in $310m deal Navidea Biopharmaceuticals said today that it inked a definitive asset purchase agreement with Cardinal Health for Navidea’s Lymphoseek product. Dublin, Ohio-based Navidea said that it will receive $80 million at closing for it’s lymphatic mapping and lymph node biopsy product, plus the opportunity for $230 million in milestone payments through 2026. More than $20 million of that amount is guaranteed over the next 3 years. Read more 4. B. Braun’s Aesculap puts nearly $3m into ApiFix B. Braun’s Aesculap division today invested $2.8 million into ApiFix’s $5 million Series B financing round to help support ApiFix’s minimally invasive, non-fusion spinal implant system designed to treat adolescent idiopathic scoliosis. The ApiFix device, which won CE Mark clearance for use in the European Union in 2012, is designed to correct adolescent idiopathic scoliosis without the use of fusion to avoid the potential for loss of spine mobility, the company said. Read more 3. Neovasc wins approvals for Eu...
Source: Mass Device - Category: Medical Equipment Authors: Tags: News Well Plus 5 Source Type: news